Tapewire

Nasdaq · USD

CRSP

CRISPR Therapeutics AG

Export transactions ↓
Tapewire entity
3852
SEC CIK
0001674416
Parsed reports
491

Last 12 months

Inside the activity.

0 purchase rows · 27 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202607
Feb 202602
Mar 2026010
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 03, 2022 Filed Dec 6, 2022 22:49 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 40,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060093 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 330,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
December 03, 2022 Filed Dec 6, 2022 22:47 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 6,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060090 · doc4.xml · derivative · entry 3

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 6,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · derivative.exercise_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022.

F1 · derivative.expiration_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022.

Read SEC document
December 03, 2022 Filed Dec 6, 2022 22:47 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon Shares 6,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060090 · doc4.xml · nonDerivative · entry 1

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · balance_after: Includes 329 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 22:36 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001209191-22-059060 · doc4.xml · derivative · entry 5

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,582

Underlying: Common Shares · 25,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 22:36 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 2,310 $55.40 $127,983.01
Disclosure

SEC source: 0001209191-22-059060 · doc4.xml · nonDerivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,279

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.27 to $55.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 22:36 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 5,572 $54.85 $305,598.01
Disclosure

SEC source: 0001209191-22-059060 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,589

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.27 to $55.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 22:36 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 17,118 $53.58 $917,245.78
Disclosure

SEC source: 0001209191-22-059060 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,161

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.36 to $54.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
November 28, 2022 Filed Nov 30, 2022 22:36 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $19.12 $478,000.00
Disclosure

SEC source: 0001209191-22-059060 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 21:43 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,418 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001209191-22-054838 · doc4.xml · derivative · entry 8

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,582

Underlying: Common Shares · 5,418 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 21:43 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 19,582 $0.00 Strike: $16.21 $0.00
Disclosure

SEC source: 0001209191-22-054838 · doc4.xml · derivative · entry 7

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,751

Underlying: Common Shares · 19,582 shares

Expires 2027-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: This option was granted on May 3, 2017 with respect to 100,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning May 31, 2017.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 21:43 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 7,188 $55.69 $400,332.78
Disclosure

SEC source: 0001209191-22-054838 · doc4.xml · nonDerivative · entry 6

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,279

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.45 to $56.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 21:43 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 11,312 $54.97 $621,774.26
Disclosure

SEC source: 0001209191-22-054838 · doc4.xml · nonDerivative · entry 5

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,467

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.45 to $55.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 21:43 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 4,000 $54.06 $216,254.00
Disclosure

SEC source: 0001209191-22-054838 · doc4.xml · nonDerivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,779

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.43 to $54.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 21:43 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 2,500 $52.73 $131,830.00
Disclosure

SEC source: 0001209191-22-054838 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 312,779

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.29 to $53.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 21:43 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 5,418 $19.12 $103,592.16
Disclosure

SEC source: 0001209191-22-054838 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 26, 2022 Filed Oct 28, 2022 21:43 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 19,582 $16.21 $317,424.22
Disclosure

SEC source: 0001209191-22-054838 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,861

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2022 Filed Oct 18, 2022 21:38 UTC
Smith BrendanChief Financial Officer
Tax withholdingCommon Shares 1,111 $55.76 $61,949.36
Disclosure

SEC source: 0001209191-22-053989 · doc4.xml · nonDerivative · entry 2

Smith Brendan · CIK 0001857492 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,639

F3 · kind: On October 14, 2021, the reporting person was granted 15,000 restricted stock units. On October 14, 2022, 3,750 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
October 14, 2022 Filed Oct 18, 2022 21:38 UTC
Smith BrendanChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 3,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-053989 · doc4.xml · derivative · entry 3

Smith Brendan · CIK 0001857492 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,250

Underlying: Common Shares · 3,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · derivative.exercise_date: The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on October 14, 2022, (ii) one quarter of the shares shall vest on October 14, 2023, (iii) one quarter of the shares shall vest on October 14, 2024, and (iv) one quarter of the shares shall vest on October 14, 2025.

F1 · derivative.expiration_date: The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on October 14, 2022, (ii) one quarter of the shares shall vest on October 14, 2023, (iii) one quarter of the shares shall vest on October 14, 2024, and (iv) one quarter of the shares shall vest on October 14, 2025.

Read SEC document
October 14, 2022 Filed Oct 18, 2022 21:38 UTC
Smith BrendanChief Financial Officer
Exercise / conversionCommon Shares 3,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-053989 · doc4.xml · nonDerivative · entry 1

Smith Brendan · CIK 0001857492 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on October 14, 2022, (ii) one quarter of the shares shall vest on October 14, 2023, (iii) one quarter of the shares shall vest on October 14, 2024, and (iv) one quarter of the shares shall vest on October 14, 2025.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
October 07, 2022 Filed Oct 12, 2022 21:42 UTC
Smith BrendanChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 14,000 $0.00 Strike: $61.65 $0.00
Disclosure

SEC source: 0001209191-22-053498 · doc4.xml · derivative · entry 1

Smith Brendan · CIK 0001857492 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Shares · 14,000 shares

Expires 2032-10-07

F1 · derivative.exercise_date: This option was granted on October 7, 2022 with respect to 14,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 7, 2022.

Read SEC document
October 07, 2022 Filed Oct 12, 2022 21:41 UTC
Morrow Phuong KhanhChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 9,380 $0.00 Strike: $61.65 $0.00
Disclosure

SEC source: 0001209191-22-053496 · doc4.xml · derivative · entry 1

Morrow Phuong Khanh · CIK 0001928989 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,380

Underlying: Common Shares · 9,380 shares

Expires 2032-10-07

F1 · derivative.exercise_date: This option was granted on October 7, 2022 with respect to 9,380 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 7, 2022.

Read SEC document
October 07, 2022 Filed Oct 12, 2022 21:40 UTC
KASINGER JAMES R.General Counsel and Secretary
GrantStock Option (Right to Buy) · Derivative 14,000 $0.00 Strike: $61.65 $0.00
Disclosure

SEC source: 0001209191-22-053494 · doc4.xml · derivative · entry 1

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Shares · 14,000 shares

Expires 2032-10-07

F1 · derivative.exercise_date: This option was granted on October 7, 2022 with respect to 14,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 7, 2022.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 21:42 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $16.21 $0.00
Disclosure

SEC source: 0001209191-22-051675 · doc4.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common Shares · 25,000 shares

Expires 2027-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option was granted on May 3, 2017 with respect to 100,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning May 31, 2017.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 21:42 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 1,800 $64.97 $116,946.00
Disclosure

SEC source: 0001209191-22-051675 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,279

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.95 to $64.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 21:42 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 23,200 $64.58 $1,498,214.24
Disclosure

SEC source: 0001209191-22-051675 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,079

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.95 to $64.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 21:42 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $16.21 $405,250.00
Disclosure

SEC source: 0001209191-22-051675 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 21:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $16.21 $0.00
Disclosure

SEC source: 0001209191-22-048166 · doc4.xml · derivative · entry 5

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,333

Underlying: Common Shares · 25,000 shares

Expires 2027-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option was granted on May 3, 2017 with respect to 100,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning May 31, 2017.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 21:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 163 $67.64 $11,025.32
Disclosure

SEC source: 0001209191-22-048166 · doc4.xml · nonDerivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,279

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 21:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 20,764 $66.98 $1,390,668.90
Disclosure

SEC source: 0001209191-22-048166 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,442

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.55 to $67.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 21:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 4,073 $66.14 $269,390.26
Disclosure

SEC source: 0001209191-22-048166 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,206

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.55 to $66.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 29, 2022 Filed Aug 31, 2022 21:45 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $16.21 $405,250.00
Disclosure

SEC source: 0001209191-22-048166 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 21:33 UTC
KASINGER JAMES R.General Counsel and Secretary
GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-046707 · doc4.xml · derivative · entry 1

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Shares · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · derivative.exercise_date: The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries.

F2 · derivative.expiration_date: The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 21:39 UTC
Smith BrendanChief Financial Officer
GrantRestricted Stock Units · Derivative 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-046714 · doc4.xml · derivative · entry 1

Smith Brendan · CIK 0001857492 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · derivative.exercise_date: The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries.

F2 · derivative.expiration_date: The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 21:37 UTC
Kulkarni SamarthDirector · Chief Executive Officer
GrantPerformance-based Restricted Stock Units · Derivative 150,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-046711 · doc4.xml · derivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Shares · 150,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F4 · shares: Represents the maximum number of shares of CRSP Common Shares that may be awarded upon the achievement of performance conditions.

F5 · derivative.exercise_date: This grant is subject to both time- and performance-based vesting. Performance-based restricted stock units will vest subject to the terms and conditions of the grant agreement evidencing the award and the Company's 2018 Stock Option and Incentive Plan. The performance conditions shall be deemed satisfied subject to achievement of certain share price targets on or before the third anniversary of the date of grant. All of the performance-based restricted stock units that have satisfied the applicable performance-based criteria shall be deemed vested on the third anniversary of the date of grant, subject to continued service to the Company or any of its subsidiaries through such date.

F5 · derivative.expiration_date: This grant is subject to both time- and performance-based vesting. Performance-based restricted stock units will vest subject to the terms and conditions of the grant agreement evidencing the award and the Company's 2018 Stock Option and Incentive Plan. The performance conditions shall be deemed satisfied subject to achievement of certain share price targets on or before the third anniversary of the date of grant. All of the performance-based restricted stock units that have satisfied the applicable performance-based criteria shall be deemed vested on the third anniversary of the date of grant, subject to continued service to the Company or any of its subsidiaries through such date.

F4 · balance_after: Represents the maximum number of shares of CRSP Common Shares that may be awarded upon the achievement of performance conditions.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 21:37 UTC
Kulkarni SamarthDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 25,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-046711 · doc4.xml · derivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Shares · 25,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · derivative.exercise_date: The restricted stock units shall vest in full on August 16, 2025, subject to continued service to the Company or any of its subsidiaries.

F2 · derivative.expiration_date: The restricted stock units shall vest in full on August 16, 2025, subject to continued service to the Company or any of its subsidiaries.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 21:36 UTC GrantRestricted Stock Units · Derivative 12,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-046709 · doc4.xml · derivative · entry 1

Klein Lawrence Otto · CIK 0001762583 · CBO & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Shares · 12,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · derivative.exercise_date: The restricted stock units shall vest in full on August 16, 2023, subject to continued service to the Company or any of its subsidiaries.

F2 · derivative.expiration_date: The restricted stock units shall vest in full on August 16, 2023, subject to continued service to the Company or any of its subsidiaries.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 16,667 $0.00 Strike: $16.21 $0.00
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · derivative · entry 10

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,333

Underlying: Common Shares · 16,667 shares

Expires 2027-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: This option was granted on May 3, 2017 with respect to 100,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning May 31, 2017.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 8,333 $0.00 Strike: $12.57 $0.00
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · derivative · entry 9

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 8,333 shares

Expires 2026-07-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: This option was granted on July 15, 2016 with respect to 93,333 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning October 31, 2016.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 600 $77.97 $46,783.02
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · nonDerivative · entry 8

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,279

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.97 to $77.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 3,308 $76.29 $252,381.88
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · nonDerivative · entry 7

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,879

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.16 to $76.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 12,759 $75.73 $966,264.59
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · nonDerivative · entry 6

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,187

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.15 to $76.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 700 $77.79 $54,455.03
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · nonDerivative · entry 5

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,946

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.345 to $77.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 700 $76.37 $53,461.10
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · nonDerivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,646

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.06 to $76.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 6,933 $75.64 $524,401.72
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,346

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.06 to $76.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 16,667 $16.21 $270,172.07
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 27, 2022 Filed Jul 29, 2022 21:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 8,333 $12.57 $104,745.81
Disclosure

SEC source: 0001209191-22-043553 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,612

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 29, 2022 Filed Jul 1, 2022 22:00 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $12.57 $0.00
Disclosure

SEC source: 0001209191-22-040343 · doc4.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,333

Underlying: Common Shares · 25,000 shares

Expires 2026-07-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option was granted on July 15, 2016 with respect to 93,333 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning October 31, 2016.

Read SEC document
June 29, 2022 Filed Jul 1, 2022 22:00 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 4,740 $62.32 $295,407.23
Disclosure

SEC source: 0001209191-22-040343 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,279

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 29, 2022 Filed Jul 1, 2022 22:00 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 20,260 $61.42 $1,244,454.29
Disclosure

SEC source: 0001209191-22-040343 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,019

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.99 to $61.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 29, 2022 Filed Jul 1, 2022 22:00 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $12.57 $314,250.00
Disclosure

SEC source: 0001209191-22-040343 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.